-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Coya Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2024 to Q2 2025.
- Coya Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2025 was $0.000.
- Coya Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2024 was -$720K, a 200% decline from 2023.
- Coya Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $724K.
Income Tax Expense (Benefit), Quarterly (USD)